Recent Approvals Show Shift in SOC for Graft-Versus-Host Disease
The treatment and preventive agent landscape for graft-versus-host disease is growing for patients with hematologic malignancies who receive a stem cell transplant.
Read More
CAR T-Cell Agents for MCL and Indolent Lymphoma
Lori A. Leslie, MD, discusses her recent presentation around chimeric antigen receptor T-cell therapy for mantle cell lymphoma and indolent lymphomas.
Watch
Patient With Newly Diagnosed Multiple Myeloma Eligible for Multiple Triplet and Quadruplet Regimens
During a Targeted Oncology Case-Based Roundtable event, Noa Biran, MD, discussed the case of a 51-year-old man with newly-diagnosed multiple myeloma.
Harper Analyzes Data for Therapies in RET-Mutated NSCLC
During a Targeted Oncology Case-Based Roundtable event, Harry Harper, MD, discussed treatment approaches for a 68-year-old patient with RET-mutated non–small cell lung cancer.
